Source link : https://www.newshealth.biz/health-news/fda-approves-bimekizumab-for-hidradenitis-suppurativa/
The US Food and Drug Administration has approved bimekizumab, a humanized interleukin (IL)-17A and IL-17F antagonist, for the treatment of adults with moderate to severe hidradenitis suppurativa (HS). Approval was based on results from two phase 3 studies, BE HEARD I and BE HEARD II, which found that bimekizumab improved the signs and symptoms of […]
Author : News Health
Publish date : 2024-11-20 17:59:53
Copyright for syndicated content belongs to the linked Source.
Categories